APA (7th ed.) Citation

Hashemi, M., Rashidi, M., Hushmandi, K., ten Hagen, T. L., Salimimoghadam, S., Taheriazam, A., . . . Falahati, M. (2023). HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response. Pharmacological research, 190, 106732. https://doi.org/10.1016/j.phrs.2023.106732

Chicago Style (17th ed.) Citation

Hashemi, Mehrdad, Mohsen Rashidi, Kiavash Hushmandi, Timo L.M ten Hagen, Shokooh Salimimoghadam, Afshin Taheriazam, Maliheh Entezari, and Mojtaba Falahati. "HMGA2 Regulation by MiRNAs in Cancer: Affecting Cancer Hallmarks and Therapy Response." Pharmacological Research 190 (2023): 106732. https://doi.org/10.1016/j.phrs.2023.106732.

MLA (9th ed.) Citation

Hashemi, Mehrdad, et al. "HMGA2 Regulation by MiRNAs in Cancer: Affecting Cancer Hallmarks and Therapy Response." Pharmacological Research, vol. 190, 2023, p. 106732, https://doi.org/10.1016/j.phrs.2023.106732.